DAY 2
Friday, 28 May 2026
8h15
Welcome coffee and registration
8h45
Keynote lecture
- Plenary
Chairman
8h45
From Patient to Platform and Back to the Clinic: iPSC-Derived Cardiomyocytes for Precision Disease Modeling and Drug Discovery
Massimiliano Gnecchi
Professor of Cardiology
Università di Pavia - Italy
Director, Translational Cardiology Unit
Fondazione IRCCS Policlinico San Matteo - Italy
9h15
Track 3: Gene Editing: Shaping the Future Today (CRISPR, microbiote, iPS, etc)
- Plenary
Chairman
9h15
Title to be confirmed
Boris Greber
Managing Director
Catalent Pharma Solutions - France
9h35
Title to be confirmed
Emiliano Ricci
Researcher
ENS Lyon - France
9h55
Title to be confirmed
Prénom Nom
Mettre à jour le poste
Entreprise - Pays
10h15
Q&A Session
10h30
Coffee break - Exhibition Hall
11h00
Roundtable
- Plenary
Chairman
11h00
To be determined
Prénom Nom
Mettre à jour le poste
Entreprise - Pays
12h00
Lunch - Exhibition Hall - B2B Meetings
14h00
Keynote lecture
- Plenary
Chairman
14h00
Title to be confirmed
Marta Coasta
Principal Scientist
iBET - Portugal
14h30
Track 4: EVs and the Secretome: From Biology to Therapy
- Plenary
Chairman
14h30
Title to be confirmed
Prénom Nom
Mettre à jour le poste
EverZom - France
14h50
Title to be confirmed
Andre Görgens
Researcher
Karolinska Institutet - Sweden
15h10
Speaker 3
Prénom Nom
Mettre à jour le poste
Entreprise - Pays
15h30
Q&A Session
15h45
Coffee break - Exhibition Hall
16h15
Track 5: Quality and Technical Challenges in Advanced Therapies
- Plenary
Chairman
16h15
Title to be confirmed
Christine Baldeschi
Researcher
I-Stem - France
16h35
Speaker 2
Prénom Nom
Mettre à jour le poste
Entreprise - Pays
16h55
Speaker 3
Prénom Nom
Mettre à jour le poste
Entreprise - Pays
17h15
Q&A Session
17h30